APAC IPOs & Placements, Aequitas Research

Hong Jie Seow

At Aequitas we cover all IPOs and placements across Asia-Pac with a deal size of at least US$100m. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

APAC IPOs & Placements

Medcaptain Medical Technology PHIP Update - Reacceleration Of Topline Growth Continues

Medcaptain Medical Technology Pre-IPO Tearsheet

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

Medcaptain Medical Technology / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/medcaptain-medical-technology-co-ltd" target="_blank" data-smartkarma-citation="entities:45767:1" rel="noopener">Medcaptain Medical Technology (MEDT HK)</a> is looking to raise at least US$100m in its upcoming Hong Kong IPO.</li>
<li>Medcaptain Medical Technology (MMT) is a global medical solution provider specializing in life support, minimally invasive intervention, and in-vitro diagnostics. </li>
<li>In this note, we look at the company’s past performance.</li>
</ul>



Medcaptain Medical Technology (MEDT HK) is looking to raise at least US$100m in its upcoming Hong Kong IPO.
Medcaptain Medical Technology (MMT) is a global medical solution provider specializing in life support, minimally invasive intervention, and in-vitro diagnostics. 
In this note, we look at the company’s past performance.


Aequitas: Medcaptain Medical Technology Pre-IPO - Topline Growth with Inflection into Profitability